Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes.
about
Apolipoprotein O is mitochondrial and promotes lipotoxicity in heartMitochondria in the diabetic heartHow exercise may amend metabolic disturbances in diabetic cardiomyopathyCardiac dysfunction and oxidative stress in the metabolic syndrome: an update on antioxidant therapiesTargeting myocardial substrate metabolism in heart failure: potential for new therapiesCreatine kinase in ischemic and inflammatory disordersClinical Phenotypes in Heart Failure With Preserved Ejection FractionMitochondrial dysfunction in diabetic cardiomyopathyDiabetes mellitus reduces the function and expression of ATP-dependent K⁺ channels in cardiac mitochondriaDiabetic cardiomyopathy: signaling defects and therapeutic approachesReduced up-regulation of the nitric oxide pathway and impaired endothelial and smooth muscle functions in the female type 2 diabetic goto-kakizaki rat heartCardiac high-energy phosphate metabolism alters with age as studied in 196 healthy males with the help of 31-phosphorus 2-dimensional chemical shift imagingMuscle oxidative phosphorylation quantitation using creatine chemical exchange saturation transfer (CrCEST) MRI in mitochondrial disordersDiagnostic approaches for diabetic cardiomyopathy.Diabetic cardiovascular disease: getting to the heart of the matter.Diabetic cardiomyopathy: pathophysiology and clinical featuresMagnetic resonance spectroscopy studies of human metabolism.Diagnostic approaches for diabetic cardiomyopathy and myocardial fibrosis.Weighted averaging in spectroscopic studies improves statistical power.Metabolic imaging in obesity: underlying mechanisms and consequences in the whole body.Foot muscle energy reserves in diabetic patients without and with clinical peripheral neuropathy.Continuous, non-invasive measurement of the haemodynamic response to submaximal exercise in patients with diabetes mellitus: evidence of impaired cardiac reserve and peripheral vascular response.Metabolic Remodeling in Diabetic Cardiomyopathy.Lipotoxicity in the heart.The role of mitochondria in the pathophysiology of skeletal muscle insulin resistance.Pathogenesis of insulin resistance in skeletal muscle.In-vivo31P-MRS of skeletal muscle and liver: A way for non-invasive assessment of their metabolism.Impaired cardiovascular function in primary biliary cirrhosis.Augmented pressor and sympathetic responses to skeletal muscle metaboreflex activation in type 2 diabetes patients.Diabetic cardiomyopathy, causes and effects.Cardiac remodeling in obesity.Evaluation of skeletal muscle during calf exercise by 31-phosphorus magnetic resonance spectroscopy in patients on statin medications.Upregulation of eNOS and unchanged energy metabolism in increased susceptibility of the aging type 2 diabetic GK rat heart to ischemic injury.Exercise-induced modulation of cardiac lipid content in healthy lean young men.Caloric excess or restriction mediated modulation of metabolic enzyme acetylation-proposed effects on cardiac growth and function.Cardiac structure and function are altered in type 2 diabetes and non-alcoholic fatty liver disease and associate with glycemic controlNew insights into insulin resistance in the diabetic heart.In vivo creatine kinase reaction kinetics at rest and stress in type II diabetic rat heart.Hyperpolarized magnetic resonance: a novel technique for the in vivo assessment of cardiovascular disease.Decreased muscle endurance associated with diabetic neuropathy may be attributed partially to neuromuscular transmission failure.
P2860
Q24294870-EA3530F8-7BC1-4078-B4F6-B7ECB8F18148Q24633336-3EAF1915-8707-48F1-AFAB-DC8EE4010A34Q26863272-09541DAF-7849-48B7-B5C7-42EBF926ABF8Q27002459-FB94D78B-C820-44C7-AED7-3005D9E7873BQ27694733-25895987-8508-4849-ABB5-43668C27BEE3Q28069271-C6189BC3-688D-4A1B-9E92-8AE6359B254AQ28073079-0D37BDFB-85CE-4CA6-AF61-0A67E5699A44Q28390863-5A00AA4E-E379-4F4D-A1AD-153A9794FFBBQ28395463-5400EC66-A460-4405-8528-FB7C138CFEBCQ28395852-F4CD3432-41E9-4226-97C0-D9CA599D7561Q28468578-044F9743-6249-49C8-A568-544E5EC11969Q28539807-12737C9E-5673-488E-B986-207EE13A8A82Q28820743-3768D8F6-AE0F-430C-AFB2-3ACCD93BB8E9Q30362092-1B91883D-1ED2-41B8-9FA6-A7FA5863A1C5Q30451529-4950E486-56B1-4A59-BAF6-36A9540D597BQ30457504-7984EDC8-657E-4620-B54D-EC53168DB6EFQ30467992-3F65CC42-63E8-447D-9187-D51A0441DAD9Q30476724-098515A2-693C-4DB0-A083-4B269E387AD9Q30490793-790D97D4-7C83-456F-BEEB-72C9984E7093Q30991322-B8A68D24-C49B-4064-834B-242EAA238353Q33464805-A72D673F-C284-42C1-9147-CADD0641307BQ33511919-41E61B68-3738-4524-94D1-20F4FB138730Q33623469-68E3AB80-F21D-4814-BC94-F4A64418C4B5Q33665107-00D0DB19-451D-4102-ACFF-337D79358694Q33779662-02472993-EBD6-4784-80DD-A44C876AC8B1Q33812448-8E422993-B64A-49EB-8809-20D9C3B87B97Q33817177-2818EF78-5A9D-4169-83EC-1D5237F094C2Q33840627-563FF864-4CDE-49F9-B968-7F9F6DA94DB2Q33891361-F8F25590-718F-4FBA-B7B3-39B1A688434FQ34038623-0D25A058-7C22-4D46-A75A-125CA6BA58D8Q34043589-AF7117AA-F6D2-4EA3-8387-4601373DEE6BQ34155702-75658054-980B-442D-980C-A65D258C54E0Q34357863-7F2D5378-3579-46DF-A801-7F680DBFCCDDQ34548132-8BBE9D57-410F-4195-B88A-6550BE486AB6Q35028393-3266C6D2-D1F2-4A1E-99AD-FBA677B07E44Q35090471-3F86B323-DFB9-4B76-A129-29E3333112B2Q35243945-5C4F3439-1B56-4291-ACF0-6AF075A9DC5CQ35294180-4C7F9043-5530-4E26-81B2-5A6AD1443F90Q35298233-BAD81535-7B82-4066-B775-D81C45A2C53CQ35437672-AF9E3FF1-7B1D-4385-B64C-6F71254B0AC3
P2860
Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes.
@en
Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes.
@nl
type
label
Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes.
@en
Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes.
@nl
prefLabel
Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes.
@en
Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes.
@nl
P2093
P1433
P1476
Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes.
@en
P2093
George K Radda
Kieran Clarke
Michaela Scheuermann-Freestone
Per L Madsen
Peter Styles
Robin E Buckingham
Stefan Neubauer
P304
P356
10.1161/01.CIR.0000072789.89096.10
P407
P577
2003-06-16T00:00:00Z